These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37407981)

  • 21. Non-syndromic retinitis pigmentosa due to mutations in the mucopolysaccharidosis type IIIC gene, heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT).
    Haer-Wigman L; Newman H; Leibu R; Bax NM; Baris HN; Rizel L; Banin E; Massarweh A; Roosing S; Lefeber DJ; Zonneveld-Vrieling MN; Isakov O; Shomron N; Sharon D; Den Hollander AI; Hoyng CB; Cremers FP; Ben-Yosef T
    Hum Mol Genet; 2015 Jul; 24(13):3742-51. PubMed ID: 25859010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Preclinical Study Evaluating AAVrh10-Based Gene Therapy for Sanfilippo Syndrome.
    Winner LK; Beard H; Hassiotis S; Lau AA; Luck AJ; Hopwood JJ; Hemsley KM
    Hum Gene Ther; 2016 May; 27(5):363-75. PubMed ID: 26975339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective Neuronal Uptake and Distribution of AAVrh8, AAV9, and AAVrh10 in Sheep After Intra-Striatal Administration.
    Mondo E; Moser R; Gao G; Mueller C; Sena-Esteves M; Sapp E; Pfister E; O'Connell D; Takle K; Erger KE; Liu W; Conlon TJ; DiFiglia M; Gounis MJ; Aronin N
    J Huntingtons Dis; 2018; 7(4):309-319. PubMed ID: 30320596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization of a large group of Mucopolysaccharidosis type IIIC patients reveals the evolutionary history of the disease.
    Martins C; de Medeiros PFV; Leistner-Segal S; Dridi L; Elcioglu N; Wood J; Behnam M; Noyan B; Lacerda L; Geraghty MT; Labuda D; Giugliani R; Pshezhetsky AV
    Hum Mutat; 2019 Aug; 40(8):1084-1100. PubMed ID: 31228227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HGSNAT enzyme deficiency results in accumulation of heparan sulfate in podocytes and basement membranes.
    Nagel L; Oliveira R; Pshezhetsky AV; Morales CR
    Histol Histopathol; 2019 Dec; 34(12):1377-1385. PubMed ID: 31157913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Klüver-Bucy syndrome associated with a recessive variant in HGSNAT in two siblings with Mucopolysaccharidosis type IIIC (Sanfilippo C).
    Hu H; Hübner C; Lukacs Z; Musante L; Gill E; Wienker TF; Ropers HH; Knierim E; Schuelke M
    Eur J Hum Genet; 2017 Feb; 25(2):253-256. PubMed ID: 27827379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential Prevalence of Antibodies Against Adeno-Associated Virus in Healthy Children and Patients with Mucopolysaccharidosis III: Perspective for AAV-Mediated Gene Therapy.
    Fu H; Meadows AS; Pineda RJ; Kunkler KL; Truxal KV; McBride KL; Flanigan KM; McCarty DM
    Hum Gene Ther Clin Dev; 2017 Dec; 28(4):187-196. PubMed ID: 29064732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HGSNAT has a TATA-less promoter with multiple starts of transcription.
    Richtrova E; Mrazova LS; Musalkova D; Luksan O; Stolnaya L; Minks J; Lukas J; Dvorakova L; Jirsa M; Hrebicek M
    Gene; 2016 Oct; 592(1):36-42. PubMed ID: 27452122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational analysis of the HGSNAT gene in Italian patients with mucopolysaccharidosis IIIC (Sanfilippo C syndrome). Mutation in brief #959. Online.
    Fedele AO; Filocamo M; Di Rocco M; Sersale G; Lübke T; di Natale P; Cosma MP; Ballabio A
    Hum Mutat; 2007 May; 28(5):523. PubMed ID: 17397050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic efficacy of bone marrow transplant, intracranial AAV-mediated gene therapy, or both in the mouse model of MPS IIIB.
    Heldermon CD; Ohlemiller KK; Herzog ED; Vogler C; Qin E; Wozniak DF; Tan Y; Orrock JL; Sands MS
    Mol Ther; 2010 May; 18(5):873-80. PubMed ID: 20179679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of novel genetic variants in the first Chinese family of mucopolysaccharidosis IIIC (Sanfilippo C syndrome).
    Zhao H; Wang L; Zhang M; Wang H; Zhang S; Wu J; Tang Y
    J Cell Mol Med; 2024 Apr; 28(8):e18307. PubMed ID: 38613342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safe, efficient, and reproducible gene therapy of the brain in the dog models of Sanfilippo and Hurler syndromes.
    Ellinwood NM; Ausseil J; Desmaris N; Bigou S; Liu S; Jens JK; Snella EM; Mohammed EE; Thomson CB; Raoul S; Joussemet B; Roux F; Chérel Y; Lajat Y; Piraud M; Benchaouir R; Hermening S; Petry H; Froissart R; Tardieu M; Ciron C; Moullier P; Parkes J; Kline KL; Maire I; Vanier MT; Heard JM; Colle MA
    Mol Ther; 2011 Feb; 19(2):251-9. PubMed ID: 21139569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-deficient mice.
    Passini MA; Watson DJ; Vite CH; Landsburg DJ; Feigenbaum AL; Wolfe JH
    J Virol; 2003 Jun; 77(12):7034-40. PubMed ID: 12768022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histological characterization of retinal degeneration in mucopolysaccharidosis type IIIC.
    Ludwig J; Sawant OB; Wood J; Singamsetty S; Pan X; Bonilha VL; Rao S; Pshezhetsky AV
    Exp Eye Res; 2023 Apr; 229():109433. PubMed ID: 36858249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
    Hammond SL; Leek AN; Richman EH; Tjalkens RB
    PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID.
    Roca C; Motas S; Marcó S; Ribera A; Sánchez V; Sánchez X; Bertolin J; León X; Pérez J; Garcia M; Villacampa P; Ruberte J; Pujol A; Haurigot V; Bosch F
    Hum Mol Genet; 2017 Apr; 26(8):1535-1551. PubMed ID: 28334745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significantly increased lifespan and improved behavioral performances by rAAV gene delivery in adult mucopolysaccharidosis IIIB mice.
    Fu H; Kang L; Jennings JS; Moy SS; Perez A; Dirosario J; McCarty DM; Muenzer J
    Gene Ther; 2007 Jul; 14(14):1065-77. PubMed ID: 17460717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector.
    Ni L; Scott L; Campbell HM; Pan X; Alsina KM; Reynolds J; Philippen LE; Hulsurkar M; Lagor WR; Li N; Wehrens XHT
    Circ Res; 2019 Jan; 124(2):256-262. PubMed ID: 30582449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drosophila melanogaster models of MPS IIIC (Hgsnat-deficiency) highlight the role of glia in disease presentation.
    Hewson L; Choo A; Webber DL; Trim PJ; Snel MF; Fedele AO; Hopwood JJ; Hemsley KM; O'Keefe LV
    J Inherit Metab Dis; 2024 Mar; 47(2):340-354. PubMed ID: 38238109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic evidence for transmembrane acetylation by lysosomes.
    Bame KJ; Rome LH
    Science; 1986 Sep; 233(4768):1087-9. PubMed ID: 3090688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.